Meeting
2023 ASCO Annual Meeting
Advancing individualized care in advanced gastroesophageal cancers (GEC): A quality improvement initiative.
Authors
Matthew Strickland
Massachusetts General Hospital, Boston, MA
Matthew Strickland , Bethany Delcuze , Ilona Dewald , Kelly E. McKinnon , Jeffrey D. Carter , Cherilyn Heggen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4051)
DOI
10.1200/JCO.2023.41.16_suppl.4051
Abstract #
4051
Poster Bd #
372
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
SAVE: A prospective, single-arm, single-center clinical study of disitamab vedotin in combination with toripalimab in patients with advanced penile cancer that has progressed or is intolerant to cisplatin chemotherapy.
First Author: Fang Yuan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The distribution of human epidermal growth factor receptor 2 (HER2) expression and the efficacy and safety of treatments in HER2-expressing advanced or metastatic gastroesophageal cancer: A systematic literature review (SLR).
First Author: David Bing Zhen
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang
Poster
2023 ASCO Annual Meeting
Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.
First Author: Makenzi Colleen Evangelist